Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents, and children recommendations for a public health approach : December 2014 supplement to the 2013 Consolidate

These guidelines provide new recommendations and updates to previous recommendations outlined in Chapter 5 (ARV drugs for HIV prevention) and Chapter 8 (Managing common coinfections and comorbidities) of the 2013 consolidated ARV guidelines. Recommendations are organized along the continuum of care....

Descripción completa

Detalles Bibliográficos
Autor principal: World Health Organization (author)
Autor Corporativo: World Health Organization, author, issuing body (author)
Formato: Libro electrónico
Idioma:Inglés
Publicado: Geneva : World Health Organization 2014.
Materias:
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009816713206719
Tabla de Contenidos:
  • 1. Introduction
  • 2. Methods
  • 3. Guiding principles
  • 4. Post-exposure prophylaxis for HIV
  • Supplementary section to Chapter 5 - HIV diagnosis and ARV drugs tor HIV prevention
  • 4.1 New recommendations on post-exposure prophylaxis tor HIV
  • 4.2 Eligibility for post-exposure prophylaxis
  • 4.3 Number of ARV drugs prescribed for post-exposure prophylaxis
  • 4.4 Post-exposure prophylaxis ARV regimens - adults and adolescents
  • 4.5 Post-exposure prophylaxis ARV regimens - children (slO years old)
  • 4.6 Prescribing frequency
  • 4.7 Adherence strategies
  • 4.8 Management of possible exposure to other conditions
  • 4.9 Follow-up
  • 4.10 Prevention
  • 4.11 Considerations for specific populations
  • 4.12 Research gaps
  • 4.13 Guidance for programme managers: implementing the key recommendations
  • 5. The use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children Supplementary sections to Chapter 8 - prevention, screening and management of common coinfections
  • 5.1 Background
  • 5.2 Co-trimoxazole prophylaxis for adults
  • 5.3 Co-trimoxazole prophylaxis for infants, children and adolescents
  • 5.4 Co-trimoxazole prophylaxis forHIV-exposed infants
  • 5.5 Implementation considerations
  • 5.6 Research
  • 6. Dissemination of the guidelines
  • References.